Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
4
×
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
4
×
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
cancer
clinical trials
eli lilly
medicaid
medicare
sanofi
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
alder biopharmaceutical
What
year
4
×
drug
big
companies
drugs
plan
price
therapies
aces
alzheimer’s
announced
answer
approval
arguments
away
bio
ceo
cholesterol
class
commercialized
competitors
decades
democratic
dems
different
discontent
election
fail
fda
flexible
gene
high
house
inclisiran
increases
key
latest
lowering
make
meant
Language
unset
Current search:
year
×
" boston blog main "
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More